Dept. of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
AccessHope, Los Angeles, CA, USA.
Curr Oncol Rep. 2022 Dec;24(12):1843-1850. doi: 10.1007/s11912-022-01332-x. Epub 2022 Oct 8.
This paper summarizes early experiences of telemedicine during the COVID-19 pandemic, the patient and physician experience, limitations in accessibility introduced by telemedicine, and the opportunities and anticipated sustained role of telemedicine for cancer care.
Research from a wide range of oncology facilities consistently demonstrates the feasibility of delivering telemedicine services over audio (telephone) and/or video platforms. Emerging work highlights that telemedicine is well suited for a subset of patients and clinical settings and that there are methods by which current disparities could potentially be ameliorated. Several current uncertainties limit the broad applicability of telemedicine longitudinally. Early responses to the pandemic that included rapid introduction of telemedicine demonstrated the feasibility of audio- and video-based platforms that achieved promising utility, while simultaneously demonstrating disparities based on patient characteristics and infrastructural support. Its long-term role will likely depend greatly on reimbursement and regulatory reform.
本文总结了 COVID-19 大流行期间远程医疗的早期经验、医患体验、远程医疗带来的可及性限制，以及远程医疗在癌症治疗方面的机遇和预期的持续作用。
来自许多肿瘤医疗机构的研究一致证明了通过音频（电话）和/或视频平台提供远程医疗服务的可行性。新的研究强调，远程医疗非常适合一部分患者和临床环境，并且有方法可以潜在地减轻当前的差距。目前有几个不确定因素限制了远程医疗的长期广泛适用性。大流行期间快速引入远程医疗的早期反应表明，基于音频和视频的平台具有可行性，并实现了有前景的实用性，同时也显示出基于患者特征和基础设施支持的差异。它的长期作用可能在很大程度上取决于报销和监管改革。
